ArticleEuropean journal of microbiology & immunology2026
Microbiome of the Eustachian tube in patients with chronic obstructive Eustachian tube dysfunction and healthy individuals.
Article in European journal of microbiology & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The Eustachian tube (ET) is essential for middle ear ventilation. Chronic obstructive ET dysfunction may lead to chronic otitis media and cholesteatoma, but its pathophysiology remains unclear. Commensal bacterial colonization of the ET has not previously been studied in healthy individuals or affected patients. Study Design and Patients: Prospective cohort study was conducted at a tertiary academic referral center including 13 patients with chronic obstructive ET dysfunction and 37 controls. Between 2017 and 2020, intraoperative tissue samples and swabs were collected using a contamination-minimized Yankauer suction technique. Samples underwent conventional culture diagnostics, microbiome analysis via 16S rDNA sequencing, and histopathological examination. Results: Culture identified 552 bacterial strains, with greater diversity in controls (34 genera) than in patients (19 genera). Microbiome analysis confirmed a larger core microbiome in controls. Rothia was more abundant in patients, whereas Veillonella predominated in controls. Genera such as Rothia and Gemella may be linked to microbial alterations in chronic ET dysfunction. Conclusion: This first combined culture-based and molecular analysis using a novel sampling-technique demonstrated reduced bacterial diversity in chronic ET dysfunction patients, resembling patterns seen in other chronic respiratory morbidities. Future studies should incorporate complementary sampling approaches and cutting-edge sequencing technologies, additionally assessing viral etiologies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.